search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
COMPOUNDS | MEDICAL


Right: Tekni- Plex Healthcare exhibited at CMEF in Shanghai,


which it says is an important platform for the company to engage with customers across China and the broader Asia region


the ISCC Plus system and produced at the com- pany’s manufacturing facility in Belfast, Northern Ireland, the compounds are a drop-in replacement for a variety of injection moulded or extruded PVC compounds utilised in a range of applications including tubing solutions and films used for trays, pouches, bags, and other form-fill-seal settings. Offering excellent cost-performance characteristics, the company claims these compounds can reduce CO2 output/emissions by up to 90% compared with conventional PVC resins. “The ability to produce a broad array of medical-grade PVC solutions with bio-based compounds is a significant step forward in healthcare materials science sustainability,” said Meg Henke, Global Head of Product Management for TekniPlex Healthcare. At the most recent China International Medical Equipment Fair (CMEF) in Shanghai, the company’s highlights included a recently developed series of radiation-resistant PVC compounds formulated to minimise yellowing and maintain material integrity. Ideal for single-use medical devices, the com- pounds are compatible with several sterilisation methods including gamma, electron beam and X-ray, while their high thermal stability reduces risks of degradation. Also on display were tracheal tube balloon PVC compounds developed for high elasticity, low friction, and exceptional stability. Combined with optimised low-adhesion proper- ties, the compounds’ low durometer helps yield soft-textured tracheal tubing that minimises patient discomfort while compatibility with various solvents facilitates easy bonding and assembly. For coronary and non-coronary angioplasty


applications, the company showcased its PTA/ PTCA balloon catheter tubing solutions, which are ISO 13485-certified and manufactured in Suzhou, China. Ranging in balloon size from 1 to 30mm, the customised tubing is manufactured at tight tolerances with concentricity of over 90%. The controlled elongation rate provides blown balloons with uniform wall thickness, improving overall yield and substantially reducing bursting risk. TekniPlex Healthcare’s tri-layer inner tubing constructs are particularly sophisticated. The solutions consist of polyamide (PA) or polyether block amide copolymer (PEBA) outer layers with high-density polyethylene (HDPE) inner layers, the small-diameter, thin-wall, tight-tolerance configura- tions used primarily in interventional vascular apparatuses. Last year, Syensqo introduced White Radel, the


latest innovation in its portfolio of Radel polyphenyl sulfone (PPSU) solutions. With its high heat and chemical resistance as well as excellent mechanical


18 COMPOUNDING WORLD | April 2026


strength and repeated sterilisability, the polymer has emerged as a cornerstone in the company’s offering for the healthcare industry. The new product is considerably whiter than traditional medical grade Radel PPSU compounds, while its high strength-to-weight ratio enhances ergonom- ics. The compounds meet strict industry guidelines and standards, including ISO 10993 biocompatibil- ity and USP Class VI approval. Design freedom and processing versatility have opened opportunities for complex geometries, part integration, and reduced manufacturing costs, while as a high-flow material, it is an ideal choice for the precise and efficient injection moulding of medical devices.


Partnerships Syensqo recently joined MedTech Innovator (MTI), the world’s largest nonprofit accelerator for medical device, digital health, and diagnostic companies, strengthening its engagement with the startup medical device community and bringing its expertise closer to early-stage development where design decisions can have more impact. “Innovation thrives across the healthcare ecosystem, from startups to established leaders, and early development is where great ideas take shape,” said Natalie Dragunat, Global Marketing Manager at Syensqo. “Through MTI, we’re expand- ing how we support innovators, sharing deep polymer know-how, application experience, and data-driven guidance to help emerging companies reach their product goals.” Specialty chemical producer Lubrizol has


www.compoundingworld.com


IMAGE: TEKNIPLEX


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42